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Dialogue systems for health communication hold out the promise of providing intelligent assistance to patients through natural inter-
faces that require no training to use. But in order to make the development of such systems cost eﬀective, we must be able to use generic
techniques and components which are then specialized as needed to the speciﬁc health problem and patient population. In this paper, we
describe Chester, a prototype intelligent assistant that interacts with its user via conversational natural spoken language to provide them
with information and advice regarding their prescribed medications. Chester builds on our prior experience constructing conversational
assistants in other domains. The emphasis of this paper is on the portability of our generic spoken dialogue technology, and presents a
case study of the application of these techniques to the development of a dialogue system for health communication.
 2006 Elsevier Inc. All rights reserved.
Keywords: Spoken dialogue system; Personal medical advisor; Prescription compliance; Artiﬁcial intelligence1. Background and motivation
Health care is rapidly becoming more elaborate and
more expensive. Greater emphasis is being placed on hav-
ing patients manage their own care in their own homes.
Patients need to be able to do such things as to manage a
complex prescription regimen or use in-home devices to
monitor and evaluate their condition. Of course, this is a
burden for many patients, who generally have trouble fol-
lowing complex instructions and cannot always interpret1532-0464/$ - see front matter  2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.jbi.2006.02.004
q This material is based upon work supported by Department of
Education (GAANN) Grant No. P200A000306; ONR research Grant No.
N00014-01-1-1015; DARPA research Grant no. F30602-98-2-0133; NSF
Grant No. EIA-0080124; and a grant from the W.M. Keck Foundation.
Any opinions, ﬁndings, and conclusions or recommendations expressed in
this material are those of the authors and do not necessarily reﬂect the
views of the above-mentioned organizations.
* Corresponding author. Fax: +1 585 273 4556.
E-mail address: james@cs.rochester.edu (J. Allen).those instructions in the changing circumstances of every-
day life.
Evidence of these problems is revealed in studies such as
those that have shown that regular phone contact by a
nurse practitioner signiﬁcantly improves the quality of life
in congestive heart failure patients [1]. Such in-home mon-
itoring by nurse practitioners, however, is not feasible in
general: there are simply not enough medical personnel
to meet the need, and it would be prohibitively expensive.
The long-term goal of this project is to develop automated
in-home conversational assistants that can help patients
manage their treatment and assist in monitoring their
health. The speciﬁc project we describe here is Chester, a
prototype spoken dialogue system that helps a patient
manage their prescriptions.
Devices are coming on to the marketplace that attempt
to address this problem. For example, voice prescription
labels provide audible label information to help the elder-
ly and the visually or cognitively impaired take their
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ing of vital signs and conditions range from glucose
meters to cardiac health monitors to a variety of wearable
or even implantable sensors.
Such technologies provide some help but fall short in
signiﬁcant ways. In particular, they do not help with the
quite common exceptions that happen on a frequent basis.
For instance, a talking pill bottle can remind you to take a
pill, but cannot help you if were out of the house, missed a
dose, and do not know whether to take a double dose now
or not. A study of voice prescription label technology
found that while visually impaired participants found the
audible voice labels useful and convenient, they indicated
that one improvement would be to support understanding
why one was taking a speciﬁc medication [2].
Of course, this information is usually available, either on
the prescription information sheet (typically lost and print-
ed in type too small for many to read) or online (where the
volume of data and the requisite computer skills are often
overwhelming). Our solution is to provide patients with a
conversational assistant that supports access to such infor-
mation using natural, spoken language. This technology
is ideally suited to home health environments for several
reasons. First, it is natural for people, requiring no training
in its use. It is eﬃcient, since it exploits humans’ highly
developed, built-in mechanisms for spoken interaction. It
is also expressive, in that one can express complex, novel
ideas using the standard mechanisms of language (and
understand same). Spoken conversation is also hands-free,
which is very desirable for systems designed to be unobtru-
sive assistants, for example in a home environment.
For such an approach to be viable, however, we need to
be able to support robust spoken language understanding
to provide reliable information. There are several aspects
to this issue. First, note that the system we describe helps
patients and/or their caregivers manage their medical care
by providing reminders, answering questions, and engaging
in dialogue to collect information for monitoring a
patient’s current state. The system does not make medical
decisions, but rather helps patients follow the instructions
that they have been given by their doctors, and provides
status reports back to medical support teams. Second, the
system provides mechanisms so that the patient can have
conﬁdence that the system has correctly understood their
questions. One obvious mechanism we use is that the sys-
tem displays what it heard on the screen for the patient
to see. Another would be to always provide a fallback to
a human caregiver, for example, by pressing ‘‘0’’ on a tele-
phone interface or clicking a button on a screen. Third, the
system does not present information that is not explicitly in
the patient’s instructions from the doctor, or information
provided about their medications. For example, if the sys-
tem says ‘‘you can take aspirin,’’ it is because this is explic-
itly in the doctor’s instructions, rather than being a
decision that the system makes on its own. And fourth,
the system is designed to require a high degree of conﬁ-
dence that it has understood the user’s question to proceedwithout any clariﬁcation or conﬁrmation from the patient.
We believe that these mechanisms can provide the eﬀective-
ness of spoken dialogue interaction without excessive risk.
Finally, for such systems to be cost eﬀective, we need
portable dialogue technology, so that the cost and time to
develop a system for a new application is only an incremen-
tal cost in adapting generic technology. The TRIPS project
is aimed at developing such generic technology, and proto-
type systems have been developed in a wide range of appli-
cations. This paper presents a case study of the issues we
faced in adapting our generic system to create a prototype
system that helps patients understand and manage their
prescribed medications.
1.1. The prescription compliance problem
Several factors are converging to create a major new
health care problem in prescription compliance. First, there
is the explosion in the number of pharmaceutical therapies
and the rate at which they are being prescribed. For exam-
ple, over 3.5 billion prescriptions were dispensed in the
United States alone in 2004 [3]. This is leading to more
patients taking more pills. Second, because of the increased
specialization of medical practice and the way patients are
assigned to specialists, these prescriptions tend to be
assigned by diﬀerent providers at diﬀerent times. This can
result in complicated (and possibly even unsafe) combina-
tions of prescriptions in a single patient’s regimen. Finally,
the problem is compounded by the fact that our population
is aging. Older patients are both more likely to have multi-
ple conditions that require separate medications, and are
often more likely to have the types of conditions that make
keeping track of these more challenging.
These trends are combining to leave patients with
unwieldy prescription regimens involving multiple medica-
tions, each with its own characteristics and requirements.
Very quickly, patients are required to spend an inordinate
amount of time ﬁguring out what to take and when to take
it. Or, worse, they simply give up and take the medication
incorrectly (or stop altogether).
The statistics show that non-compliance is a serious
problem. One study showed that non-compliance causes
125,000 deaths annually in the US [4]. A review of the lit-
erature based on electronic monitoring of drug consump-
tion concluded that mean dose-taking compliance ranged
from an already poor 71% (±17%) for once-per-day drugs
to just 51% (±20%) for drugs meant to be taken four times
per day [5]. The New York Times has labeled non-compli-
ance ‘‘the world’s other drug problem’’ [6]. Whatever the
reason, it is clear that a signiﬁcant percentage of patients
simply do not (or cannot) comply with their prescribed
drug regimen.
1.2. Conversational systems
Conversational systems enable naı¨ve users to interact
with complex applications in a natural way using speech,
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grate many diﬀerent technologies that have been developed
individually: speech recognition, language understanding,
planning and reasoning, language generation, text-to-
speech synthesis. As these underlying technologies as well
as dialogue technology itself have matured, research sys-
tems have been developed in numerous domains, while suc-
cessful systems of more limited ﬂexibility have started to be
deployed commercially. At the same time, the focus of dia-
logue systems research has evolved to include issues of por-
tability, modularity, and dynamic conﬁgurability [8].
Within this paradigm, we have for some years been
developing conversational assistants: computer systems that
interact with their users using spoken natural language to
help them solve problems. Starting from corpus studies
gathered using a ‘‘Wizard of Oz’’ setup [9,10], we have built
a sequence of prototype collaborative planning systems
[11–13]. More recently, we have been extending this work
to several new domains including an assistant to a supervi-
sor in a crisis management center [14], a purchasing assis-
tant, an assistant for managing teams of robots engaged
in search and rescue [15], and the Medication Advisor
described in this paper. A key aspect of our research is that
a single set of generic spoken dialogue software compo-
nents should be used to handle all of the diﬀerent applica-
tions. Our main motivation for this is that we believe it will
not be economically feasible to build such complex systems
from scratch for each application.
From a technical perspective, the medication compli-
ance problem seems like a relatively circumscribed domain
in which it might be possible to develop an intelligent com-
puter assistant. The major problems involve maintainingMedical 
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Fig. 1. Chester in the TRIPS architecturethe patient’s medication schedule (notifying them as appro-
priate, helping with rescheduling, etc.) and answering ques-
tions about the schedule and the drugs involved. This paper
describes the problems we faced as we built an initial pro-
totype of a system that assist patients in their own home
using intuitive and natural communication mechanisms.
2. The TRIPS environment
Our initial prototype of the Medication Advisor is based
on the architecture developed for TRIPS, The Rochester
Interactive Planning System [16], shown in Fig. 1. Compo-
nents are shown as ovals, and knowledge sources as square
boxes. Generic parts are shown with white backgrounds,
and the domain speciﬁc parts are shown in gray. Broadly
speaking, the components are divided among three main
categories: interpretation, behavior, and generation, and
the knowledge sources often are shared across several cat-
egories. The interpretation components involve under-
standing what the user has said or done, the behavior
components manage the systems goals and reasoning,
and the generation components construct system contribu-
tions to the dialogue. We consider each brieﬂy.
Interpretation: The ﬁrst stage of interpretation is speech
recognition, which draws its vocabulary from the common
lexicon for the system, and produces a list of possible inter-
pretations for processing by the Parser. The Parser uses a
general lexicon and grammar of spoken dialogue utterances
(developed incrementally over several previous applica-
tions), and produces a meaning representation expressed
in a domain independent semantic representation (the logi-
cal form). The interpretation manager receives the ParserLexicon
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with domain speciﬁc aspects in gray.
Fig. 2. Screenshot of user talking to Medication Advisor.
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referring expressions such as pronouns and deﬁnite noun
phrases and interacts with the Task Manager which per-
forms plan and intention recognition. It also applies a set
of ontology mapping rules to convert the generic semantic
representation into the domain speciﬁc representation for
Chester. It identiﬁes the most likely intended speech act
(c.f. [17]) in the form of a collaborative problem solving
action, and updates the Discourse Context. A more detailed
analysis of the problem-solving model, including an exam-
ple in the Medication Advisor domain, is presented in [18].
Behavior: The Behavioral Agent is the autonomous
‘‘heart’’ of the agent. It takes the collaborative problem solv-
ing act produced by the interpretation manager and per-
forms further intention recognition and then plans system
behavior based on its own goals and obligations, the user’s
utterances and actions, and changes in the world state.
Actions that require task- and domain-dependent process-
ing are performed by the Task Manager. Actions that
involve communication and collaboration with the user
are sent to the Generation Manager in the form of commu-
nicative acts. Chester contains several domain-speciﬁc com-
ponents, including a medication knowledge base and a
rudimentary scheduling algorithm to reason about prescrip-
tions. These domain speciﬁc aspects of the system formed the
bulk of the work we had to perform to construct the system.
Generation: The Generation Manager coordinates plan-
ning of the system responses. Generation is typically divid-
ed into content planning, where the content of the system’s
utterance is planned, and surface realization, where the
actual words to be spoken are constructed. Its behavior is
driven by discourse obligations (stored in the Discourse
Context), and the directives it receives from the Behavioral
Agent. The glue between the layers is an abstract model of
problem solving in which both user and system contribu-
tions to the collaborative task can be expressed. While con-
tent planning is domain-speciﬁc in TRIPS, the surface
realization is performed by an independent surface realiza-
tion component [19].
2.1. System demonstration
TheMedication Advisor prototype appears to the user as
shown in Fig. 2. In addition to displaying the system’s
understanding of the user’s speech and the conversation thus
far (at the bottom of the screen), the system is embodied as a
graphical avatar in the shape of a pill. This could perform a
few actions to convey the system’s state, for example, idle,
attentive, thinking, and speaking. The thinking and atten-
tive states proved most valuable in indicating when Chester
required extra processing time and expected the user to wait
before moving on.While the actions and visualization of the
avatar were very simple, they provided invaluable informa-
tion and a natural focus of attention for the users.
Fig. 3 shows a dialogue which we often use when dem-
onstrating the system. This dialogue, designed in collabora-
tion with our medical collaborators, was created toshowcase the capabilities of the system and the potential
for addressing the compliance problem. The user is an
elderly woman, who is taking a small number of commonly
prescribed medications. She wakes up with a headache and
decides to ask Chester for help.
The user starts by asking a simple question:
Patient: Can I take an aspirin? (1)The system interprets this as either a yes–no question
about the ability to take aspirin, or as a suggestion to take
aspirin (now, i.e., at the time of the utterance). In either
case, the system must ﬁrst verify whether taking aspirin is
possible. Note that it must identify that the user is asking
about whether it is advisable given their medical situation,
not whether they could physically swallow a pill. All of
these decisions require the capability to recognize the inten-
tions underlying utterances (see Section 3.4). Once the cor-
rect intention is identiﬁed, Chester cross-references its
knowledge about the user’s prescriptions with its knowl-
edge base of drug interactions and side-eﬀects. Since this
search turns up an interaction with one of the prescribed
medications, the system can immediately answer that tak-
ing aspirin is not permissible:
Chester: No, you are taking Celebrex and Celebrex (2)
interacts with aspirin.The user goes on to ask another question:
Patient: Oh. Could Celebrex cause headaches? (3)At ﬁrst glance, this is yet another yes–no question. The
system could simply look up the answer using its knowledge
bases and tell the user the answer. However, it is here that we
begin to see the diﬀerence between a simple natural language
front-end to a database query system and a true conversa-
tional assistant. As part of interpreting the user’s utterance,
the system again attempts to recognize the intention behind
the utterance—that is, why she said what she did. In this
Fig. 3. Demonstration dialogue for Chester.
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hypothesis that the user is trying to treat a symptom (head-
ache) with an over-the-counter remedy (aspirin). This
hypothesis regarding the user’s intention was initially creat-
ed during the processing of utterance (1), but at that time
there was not yet suﬃcient evidence for the system to take
action based on it. With the additional evidence from (4),
the system is reasonably conﬁdent that the user has a head-
ache that they are trying to treat. As part of its response to
this type of user action, it consults its knowledge bases to
determine whether such a situation requires action on its
part. It turns out that, in this scenario, one of the other med-
ications that the patient is prescribed for can result in severe
headaches, and that if these occur, it is a serious condition
that should be reported to the doctor immediately.
So, to summarize, the literal answer to the question
about Celebrex causing headaches is no. However, the sys-
tem decides to take the initiative in the conversation and
resolve the issue about the user’s headache, since it is
potentially serious. The result is the following utterances:
Chester: No, headaches are not an (4)
expected side-eﬀect of Celebrex.Chester: Do you have a headache? (5)After the user answers yes, Chester seeks to clarify the
severity of the headache.
Chester: How severe is your headache on a scale (7)
of one to ﬁve?Patient: One. (8)
Chester: Your doctor says you can take Tylenol
for mild headaches.
(9)Patient: Ok, I’ll try that. (10)The form of the question in (7) was suggested to us by
our medical colleagues. The information used in utterance
(9) comes from explicit instructions from the doctor associ-
ated with the prescription (i.e., if the headache had been
severe, Chester would have recommended the patient call
her doctor immediately).
With the headache issue resolved, the system returns the
initiative in the conversation to the user, who decides to
pursue her original line of questioning regarding Celebrex.
The remainder of the dialogue illustrates the sorts of ques-
tions that might reasonably arise in a Medication Advisor
context.
Patient: Why am I taking Celebrex? (11)
Chester: You are taking Celebrex to help with
your arthritis.
(12)The reason for taking a medication is an important
aspect of the extended notion of ‘‘prescription’’ required
to support this kind of dialogue.
Another capability that we wanted to emphasize is the
system’s ability to reason about when the medications are
supposed to be taken (as opposed to the ‘‘why’’ emphasized
thus far in the dialogue). This is an ideal problem for AI-
based scheduling technology to help people by giving
reminders and answering questions about when they
should take their pills (see Section 4.5). So, for example,
the user continues:
Patient: Should I take one now? (13)
Chester: Yes, you are taking Celebrex every
morning.
(14)Patient: Is there anything else I need to take now? (15)
Chester: Yes, you should take your Prinivil. (16)
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pill, and Chester responds by showing a picture from its
medication knowledge base.Patient: Which one is that? (17)
Chester: It’s the yellow one. [shows picture] (18)Fig. 4. Alternative pronunciations obtained automatically for the word
OSTEOPOROSIS.In the rest of the dialogue, the user follows up on her
earlier headache question and then completes the dialogue.
Although the system is fully implemented, it is far from
a robust, complete product suitable for ﬁelding in real sit-
uations. Speciﬁcally, its knowledge base contains informa-
tion on only 10 medications, it has no user adaptation in its
speech recognition that would be required for high-accura-
cy recognition, it does not have a full range of common
user goals that would be typical in real use of the system,
and attaining suﬃcient linguistic coverage will require fur-
ther extensions to the lexicon, grammar, and ontology. It
does, however, provide a demonstration of potential feasi-
bility of such technology, and we are currently working to
resolve the problems above to produce a system suﬃciently
capable to support controlled experiments in usability and
medical eﬀectiveness.
In the rest of this paper, we describe the technical chal-
lenges we faced in building this initial version of Chester.
3. Customization of the interpretation processes
One of the challenges facing developers of a dialogue
system in new domains is building the various models of
language needed for eﬀective processing. The typical way
to address this problem these days is by collecting a corpus
of training data. But this is not a workable strategy for
most dialogue applications. It is typically very expensive
to collect and annotate large amounts of dialogue relevant
to a system that does not exist yet. We have been pursuing
a diﬀerent approach that involves using generic language
models, including statistical n-gram models (c.f. [20–22])
trained from a variety of other dialogue domains, a generic
lexicon that at the time covered approximately three thou-
sand of the common core English words (lemmas; standard
morphological variations are generated automatically in
the lexicon), and a comprehensive grammar of spoken dia-
logue that was and still is under continual development
using data from multiple domains. In addition, we have
generic components for discourse processing [23], including
speech act identiﬁcation [24,25], reference resolution [26,27]
and ellipsis processing (c.f. [28,29]). This section describes
what we needed to do to adapt the generic components
to produce an eﬀective interpretation system for Chester.
3.1. Language and pronunciation modeling
Two important components of a speech recognition sys-
tem are the language model and the pronunciation dictio-
nary (also called lexical model). In our previous work on
spoken dialogue applications, we devised a technique forquickly building language models for new task domains
that has delivered very good performance [30]. Pronuncia-
tions were drawn from the 120,000-word general-purpose
CMU dictionary [31], which provided satisfactory coverage
for our applications. Unfortunately, for domains like the
Medication Advisor, this may not always be possible, as
general purpose dictionaries by their nature tend to have
limited coverage of specialized lexicons, whereas domain-
speciﬁc dictionaries may not even exist.
The seriousness of the problem is compounded by the
fact that, even if a canonical pronunciation can be
obtained, it is not safe to assume that it will be known
and used by uninformed users of the system. In previous
research it has been shown that adding non-canonical pro-
nunciations in the lexical model helps improve the speech
recognizer’s performance [32]. We expect that the same will
be true in the Medication Advisor domain. Moreover, we
propose that these non-canonical pronunciations—as well
as pronunciations for out-of-dictionary words—can be
generated automatically.
For illustration, in Fig. 4, under the heading ‘‘Automat-
ic (1),’’ we give examples of pronunciations for a medical
term in our lexicon, obtained automatically with a
domain-independent grapheme-to-phoneme converter
[33]. We expect that general grapho-phonotactic knowl-
edge gleaned out of a general purpose dictionary will be
suboptimal for the medical domain. One way to improve
the quality of our models is to learn automatically
domain-speciﬁc constraints from medical dictionaries that
give guides to pronunciation (e.g., [34]). For example, the
alternative pronunciations listed in Fig. 4 under the head-
ing ‘‘Alternative (2)’’ are obtained by running the same
converter on the string ‘‘OSS-tee-oh-pa-ROW-sis,’’ which
is the pronunciation indicated by the National Cancer
Institute on their website.
Additional improvementsmay be obtained by associating
probabilities to alternative pronunciations and adapting
them dynamically; this way we can personalize the pronun-
ciation dictionary to speciﬁc users and correct the possible
errors introduced by the grapheme-to-phoneme converter.
3.2. Adapting the lexicon and ontology
The TRIPS grammar and lexicon provide broad cover-
age for a variety of constructions common in practical dia-
logue including questions, imperatives, and fragmentary
utterances such as noun or prepositional phrase fragments
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Medication Advisor domain, we augmented our lexicon
with names for medications, symptoms, and medical condi-
tions, as well as with previously missing domain-indepen-
dent senses for existing words, such as a Consume sense
of take to handle utterances such as ‘‘Can I take an aspi-
rin,’’ and similarly for have, as in ‘‘I like to have an antacid
before bedtime.’’
The domain-independent semantic representation (a
logical form) produced by the parser is designed to be suit-
able for discourse processing, and it is used by components
handling reference resolution and dialogue management as
input for further processing. The logical form representa-
tion is based on a domain-independent language ontology.
The reasoning components use a domain-speciﬁc ontology
optimized for reasoning in the medication domain, using
specialized concepts as described in Section 4. To connect
the two, we use a set of mappings between the ontologies
and a transform engine that converts the syntax of the log-
ical form to the domain-speciﬁc syntax used by the reason-
ers. These mappings tailor the generic logical form to the
needs of the reasoning components built for a particular
domain.
The ontology mapping facility also allows us to improve
parsing speed and accuracy on in-domain utterances. A
specialization algorithm automatically propagates
domain-speciﬁc selectional restrictions into the lexicon
for entries that have domain-speciﬁc mappings, tightening
the constraints on words relevant to the domain. Word
senses with domain-speciﬁc mappings are preferred, allow-
ing the parser to ﬁnd a correct interpretation faster. This is
especially helpful for words such as take, which have a
large number of senses, resulting in a high degree of ambi-
guity. In the Medication Advisor domain, the Consume
sense of take as in (1) is strongly preferred and will be con-
sidered ﬁrst, as opposed to the Transport sense of take.
Our lexicon specialization signiﬁcantly boosts parsing
speed and accuracy compared to the generic parser, as dis-
cussed in Section 5.1.
3.3. Interpretation and reference resolution
We found two key challenges for discourse interpreta-
tion in the Medication Advisor domain. One arose from
an increased occurrence of reference to kinds rather than
individuals or sets. Medicinal substances are of course fre-
quently mentioned in this domain, and often they must be
interpreted as kinds. For example, in utterance (2) above,
‘‘Why am I taking Celebrex?’’ the word Celebrex refers
to the kind, not to any particular instance of Celebrex.
Interpreting references to kinds required us to extend to
the grammar, the logical form language, and the reference
resolution algorithms.
The second interpretation challenge in this domain was
that the language used to speak about medical conditions
and treatments abounds with metonymy (mentioning one
item in a conventional way to refer to a related item).For example, in ‘‘I need to know when to take my prescrip-
tion,’’ my prescription is a metonymic reference to the med-
ication associated with the speaker’s prescription (since one
cannot literally take a prescription). This metonymic
phrasing must be coerced back to the correct argument
type for reasoning. The back-end reasoners do not know
how to place a PRESCRIPTION object in a TAKE-MEDI-
CINE event, and therefore the dosing schedule that the user
is requesting cannot be created. Rather, a MEDICATION
object is expected by the back-end planner. This situation
creates an asymmetry between the representations built
for the language-processing front-end and the back-end
reasoning system. We want to allow the parser to accept
‘‘take my prescription’’ as an acceptable sentence, even
though it violates the argument restrictions in place in
the back-end. We cannot solve this problem by removing
all restrictions from the parser, because we still want it to
reject truly unacceptable combinations, such as ‘‘*I need
to know when to take my shoe.’’
Our solution was to create a set of inference rules that
specify the relationships between certain object types that
are commonly used in metonymic constructions in this
domain. Using the inference rules, the interpretation of
‘‘my prescription’’ in ‘‘I need to know when to take my pre-
scription,’’ is transformed into ‘‘the medication of my pre-
scription.’’ The inference rule adds both the relationship
(medication-of) and the additional hidden argument to
the interpretation of the sentence, so that the reasoner in
charge of building the dosing schedule receives a MEDICA-
TION argument as expected.
3.4. Plan and intention recognition
A vital step of dialogue understanding in the Medi-
cation Advisor domain is intention recognition. Inten-
tion and plan recognition go beyond what was said
and look at why it was said. What did the user hope
to accomplish by uttering this? What prompted him to
utter it?
Intention recognition is critical since similar language
patterns can be based on diﬀerent underlying user goals
and need to be handled in very diﬀerent ways. Take, for
example, the following two utterances, the second of which
is from the example dialogue in Fig. 3:
(1) ‘‘Can I take a Celebrex?’’
(2) ‘‘Can I take an aspirin?’’
While these utterances are identical in structure, the
user’s underlying goals behind these utterances can be very
diﬀerent. Let us assume, for this example, that we know
that the user has a prescription for Celebrex, but does
not have a prescription for aspirin. Because we know that
the user has a prescription for Celebrex, we can infer that
the intention behind the ﬁrst utterance is that he is likely
querying about a previously deﬁned medication schedule.
For the second utterance, however, there must be some
J. Allen et al. / Journal of Biomedical Informatics 39 (2006) 500–513 507other motivation for asking about taking the medication. It
may turn out, as it does in our sample dialogue, that the
user has a headache, and desires to take aspirin to get rid
of the symptoms. This intention requires a very diﬀerent
response from the system than that of the ﬁrst utterance.
To capture the user’s intentions, we identify two aspects
of intention: the collaborative problem solving act between
the user and the system, and the domain goal/plan. We con-
sider each of these brieﬂy.
Communicative intentions capture how each agent tries
to individually aﬀect the joint problem-solving state.
Together, the system and user do things like adopting
objectives, formulating and choosing recipes (prototypical
plans), and creating and executing solutions. The details
of our collaborative problem solving model can be found
in [18,35]. While the collaborative problem-solving model
is domain independent, it utilizes a domain-dependent plan
library which provides the system with knowledge of
domain-level objectives, recipes, and resources [36].
To obtain the domain knowledge for the Medication
Advisor domain, we analyzed a set a questions from an
online medication FAQ. Some representative objectives
found in the FAQ include evaluating possible drug interac-
tions, taking over-the-counter drugs, managing medication
schedules, querying medication schedules, stopping unde-
sirable symptoms, assessing side-eﬀects, and deﬁning med-
ical terminology. A subset of these goals were encoded,
together with corresponding recipes, to be used with the
plan/intention recognition system.
We analyze here, the ﬁrst few exchanges of the sample
dialogue in Fig. 3 in order to show how plan and intention
recognition proceed in the system. We reprint part of the
dialogue here for the reader’s convenience.
Patient: Can I take an aspirin? (1)
Chester: No, you are taking Celebrex and Celebrex
interacts with aspirin.
(2)Patient: Oh. Could Celebrex cause headaches? (3)
Chester: No, headaches are not an expected
side-eﬀect of Celebrex.
(4)Do you have a headache? (5)The user starts with utterance (1), which the system must
interpret. Intention recognition sees that the user does not
have a prescription for aspirin, but that aspirin is an over-
the-counter drug. The communicative intention inferred is
that the user and system jointly evaluate the domain plan
of the user taking an over-the-counter drug, namely aspi-
rin. With this intention now known, the rest of the system
(back-end reasoners) determines that it is not a good idea
for the user to take aspirin, since she is taking Celebrex
and aspirin and Celebrex interact. This is generated and
becomes utterance (2) by the system.
The user does not seem to have intended that the system
understand why he wants to take aspirin. However,
through plan recognition, the system realizes that taking
an over-the-counter drug is not an end goal, or an objectiveunto itself (c.f. [37]). Rather, it is a means towards a higher-
level objective. However, there is not yet enough informa-
tion for the system to make an inference.
The user then makes utterance (3). Intention recognition
recognizes this as an intention to identify some fact in the
situation, speciﬁcally, if headaches are a side-eﬀect of
Celebrex. Back-end reasoners ﬁnd that this is not the case,
resulting in the system’s utterance (4).
At the same time, utterance (3) gives plan recognition
suﬃcient information to make a guess about the user’s high-
er-level goals. In the system’s plan library, the plan on tak-
ing an over-the-counter medication is part of a larger
objective to relieve a symptom. The system knows that aspi-
rin can relieve headaches and infers that the user’s higher-
level objective is possibly relieving a headache. However,
the system is not sure about this inference, so it produces
utterance (5) to conﬁrm it. Such plan recognition enables
the system to be helpful (c.f. [38]). Later in the exchange
the system, based on this inference, is able to take initiative
and suggest that the user take Tylenol for her headache.
Chester is able to perform intention recognition eﬀective-
ly because of the limited number of goals we have encoded.
We are currently developing techniques for eﬀective and eﬃ-
cient intention recognition over large plan libraries by com-
bining statistical and symbolic techniques ([39]).
4. Building the reasoning components
The bulk of the development eﬀort in Chester involved
developing the medical knowledge base and the reasoning
engines required for the task. Such components clearly dif-
fer dramatically from task to task and thus inevitably will
remain domain dependent. The goal of our work, however,
is that once such components are built for a domain, creat-
ing the dialogue system on top of it is relatively low eﬀort.
Furthermore, many of the domain-dependent reasoners are
built using generic technology originally developed for
other domains.
4.1. Knowledge acquisition
In the Medication Advisor prototype, a crucial compo-
nent is the system’s knowledge base of prescription drugs
and over-the-counter medications. The preliminary knowl-
edge base was built using a process that combined auto-
matic knowledge extraction and manual correction of the
extracted knowledge.
Our starting point for the knowledge base was the
public MedlinePlus Health Information web site [40] pro-
vided by the National Library of Medicine and the
National Institutes of Health. This site provides reference
information for thousands of drugs for both the US and
Canada. Since the site was designed for the average web
user, most of the information is described using English
sentences and the main task during knowledge acquisi-
tion was to extract the relevant information from this
English.
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each page: substance to brand name mappings, dosing
schedules, and substance eﬀects. We used a combination
of HTML extraction rules and simple text patterns to
extract the brand names and dosing information. Unfortu-
nately, the third type of knowledge, substance eﬀects, is not
as simple. Our automated system was helpful in determin-
ing when a drug interaction was listed, but pulling the
semantics out of the natural English was diﬃcult and left
to the human researcher.
4.2. Representing knowledge about drugs
One of the main functions of the Medication Advisor
knowledge base is to represent drug interactions and their
eﬀects. However, classifying drug interactions proved to
be a diﬃcult problem. The following examples show the
ambiguity that arises from MedlinePlus’s descriptions of
drug interactions (all taken from its description of ‘‘Anti-
histamines (Systemic)’’ [41]):
(1) Troleandomycin—Use of these medicines with astem-
izole or terfenadine may cause heart problems.
(2) If you are now taking, or have taken within the past 2
weeks, any of the MAO inhibitors, the side eﬀects of
the antihistamines, such as drowsiness and dryness of
mouth, may become more severe.
(3) Make sure you know how you react to the antihista-
mine you are taking before you drive, use machines,
or do anything else that could be dangerous if you
are not alert.
(4) Antihistamines are used to relieve or prevent the
symptoms of hay fever and other types of allergy.
The richness of these descriptions made their representa-
tion a challenging research problem as well as an important
application domain.
Example (1) is representative of the most prevalent class
of interactions listed in MedlinePlus. It is a drug-to-drug
interaction that speciﬁes the substances that interact and
what eﬀect results. Obviously, drugs interact with other
drugs. However, the temporal constraints on such an inter-
action are both ambiguous and undeﬁned (contrast with
(2)). In the development of the knowledge base we made
several assumptions about the correct interpretation of
these constraints. This is one of several areas where a more
formal oversight process would be required before the sys-
tem was deployed.
Example (3) shows that we need to represent substance
interactions with other ‘‘events’’ instead of just other sub-
stances. In this case, the event (or act) of operating machin-
ery should be avoided when taking antihistamines. Finally,
example (4) shows a case that is neither drug-to-drug nor
drug-to-event, it describes the eﬀects of a substance on a
symptom.
Without going into the details, we represented these and
a wide range of similar statements using three basic eventexpressions: having a condition, taking a substance, and
doing an activity. A history-of operator allows us to
describe past events. Thus for example (2) we get:
(history-of (taking MAO-inhibitor) (weeks 2))
It is worth noting that such qualitative relationships
between events are much more frequent in MedLinePlus
than any kind of simple metric constraints.4.3. Drug eﬀects and interactions
With all activities represented as events, and a semantics
for time periods adequately deﬁned, the next step was to
represent the eﬀects of a substance when taken within dif-
ferent contexts. The schematic form of these rules can be
paraphrased as: ‘‘Under conditions C with timing T, the
prescription constraint P applies. For each side-eﬀect, the
eﬀect E will occur with frequency F. Further, if it is
observed, then it indicates a problem of severity S and
the patient’s response should be R.’’ The condition C is
the drug interaction, such as (AND (taking MAO-
inhibitor) (doing machinery)). The prescription
constraint P has a variety of options, but the most common
is doctors-permission, meaning ‘‘when prescribed by
a doctor.’’
The key representational challenge here was the repre-
sentation of eﬀects. The common example of aspirin would
lead us to a conclusion that substances lessen the degree of
a side-eﬀect (as aspirin lessens pain). However this is only
one in a set of many types of eﬀects. The following are a
few examples from the MedlinePlus database that we need-
ed to represent:
(1) Although not all of these side eﬀects may occur, if
they do occur they may need medical attention. . .
cough; diarrhea; diﬃculty swallowing; dizziness; fast
heartbeat; fever; headache. . .
(2) (acetaminophen taken while having) liver disease—
The chance of serious side eﬀects may be increased.
(3) Acetaminophen is used to relieve pain and reduce
fever.
(4) Salicylates can make this condition (Gout) worse and
can also lessen the eﬀects of some medicines used to
treat gout.
Again, without going into the details, we introduced a
number of attributes of events, such as severity-of,
chance-of, and eﬀectiveness-of. Drug eﬀect (or interaction)
rules are then formulated in terms of increase or decrease
of these attributes. Thus the eﬀect in example (2) is:
(increase (chance-of (having serious-
side-effects)))
and that of example (4) is:
(decrease (effects-of (taking medicines-
used-to-treat-gout)))
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After formalizing the representation for drug interac-
tions and side-eﬀects, the ﬁnal task was to represent the sec-
tion of MedlinePlus which describes proper dosing for the
drug substances. The schematic form of these rules can be
paraphrased as ‘‘Do A at rate R with restrictions X for pur-
poses of eﬀect E.’’ The action A is typically taking a med-
ication, the rate R is something like ‘‘1 to 2 mg every
eight to twelve hours,’’ and the intended eﬀect E is as
described above. Where appropriate, we also encoded an
action to be performed when a dose was missed (for exam-
ple ‘‘take now or skip if close to next’’ or ‘‘contact doc-
tor’’). These rules form the core knowledge of the system
about when and how the patient’s medications should be
taken.
4.5. Medication scheduling
The scheduling component of the Medication Advisor is
used to generate relatively optimal, safe, and dynamically
adaptive schedules given necessary information about the
patient’s prescriptions. Input to the scheduler consists of
two types of information:
(1) Information regarding prescribed medications (name,
dosage and rate, etc.);
(2) Information describing constraints on taking the
medication, including timing constraints (e.g., ‘‘take
before bed’’), activity constraints (e.g., ‘‘do not take
with food’’), and drug interactions, including with
over-the-counter drugs.
Additional scheduler input comes in the form of events
such as the patient missing a dose.
From this information, the scheduler generates a sche-
dule taking into account all known constraints. If a new
prescription is added, the system should adjust its schedule
to satisfy the new constraints if needed. In addition, some
of the constraints are ‘‘soft,’’ such as ‘‘It is preferable to
take Medicine A at least 3 h before a meal.’’ The system
should be able to ﬁnd the best schedule which satisﬁes as
many soft constraints as possible. Finally, when some
dynamic changes happen, the system should be able to
adjust the schedule to adapt to the new conditions. The
remainder of this section brieﬂy describes our initial
approach to these requirements.
First, we needed a temporal representation that facilitat-
ed the generation of a quantitative schedule from a set of
mixed qualitative and quantitative constraints. After con-
sidering several options, we settled on a quantized repre-
sentation that divided each day into half-hour units. By
quantizing time this way, the number of possibilities the
scheduler must consider is dramatically reduced, and the
ﬁnal schedule is easy for people to understand and follow.
An important aspect of the temporal content of pre-
scriptions is that information is often expressed relativeto prototypical events, such as breakfast, lunch, dinner,
mealtime, bedtime, and so on. For example, ‘‘medicine A
must be taken within 3 h of lunch time,’’ ‘‘medicine B
can be taken 6 h before bedtime,’’ and so on. To capture
this, we chose a constraint-based representation of events.
Each primitive constraint relates the time of taking the
medication to the prototypical events. We should note this
is not suﬃcient to capture the complete range of dosing
information seen in MedlinePlus (and represented in the
knowledge base as described above). For example, some
medications are prescribed to be taken ‘‘as needed for
pain.’’ Others involve taking varying amounts depending
on other circumstances. In any case, our representation
can handle a fairly wide range of dosings, in particular
those that are possible to schedule deﬁnitively.
Given this representation, it was clear that part of the
prescription scheduling problem could be formulated as a
constraint–satisfaction problem (as reviewed in [42], for
example). Other aspects, however, look more like an opti-
mization problem. For instance, a good prescription regi-
men would tend to minimize the number of times a day
that medication needs to be taken. In this initial implemen-
tation, Chester could verify that a certain prescription reg-
imen was consistent with the stated prescriptions, but was
not required to generate optimal schedules. We are current-
ly working on developing richer algorithms for prescription
scheduling that will be used in the next version of the
system.
Finally, another challenge for the scheduling system is
that it must be able to adjust the schedule in light of certain
changes, such as the patient forgetting to take a medicine at
the right time. The appropriate repair strategy is con-
strained by requirements speciﬁed in MedlinePlus, such as:
‘‘Medicine A should be taken at once if missed, unless it
is less than 2 h until the next dose, in which case you
should skip the dose.’’
The original Chester scheduler could verify some chang-
es proposed by the user, but did not solve this problem in
any generality. This is also a challenging area for future
research (as described, for example, in [43]).
5. Component evaluations
We have performed a number of component evaluations
that indicate the plausibility of being able to construct a
robust, usable dialogue system from generic components.
In this section, we brieﬂy summarize some of these compo-
nent evaluations, and provide pointers to where these
results have been presented in more detail.
5.1. Evaluating parsing and domain customization
To assess portability, we evaluated the coverage of our
generic grammar on a set of ﬁve human–human dialogues
in the Medication Advisor domain after adding missing
lexical entries, but not extending the grammar. The parser
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resentations for 70% of the 294 utterances, judged for cor-
rectness by trained annotators (inter-annotator reliability
in our crisis management domain has a kappa score of
0.79 [44]). Our exact match evaluation requires not only
syntactic constituent accuracy (the standard for statistical
parser evaluations [45]) but also correct word sense disam-
biguation and predicate-argument relation assignment,
which are key for eﬀective interpretation. Note that this
score represents a lower bound on parser coverage, because
the correct parse may be ranked as a second or third alter-
native. This result shows the generality of the grammar and
lexicon, as we obtain 70% complete and correct sentence
interpretations before we have put any eﬀort into extending
the grammar for the new domain. Our previous research on
other domains has shown that additional development sig-
niﬁcantly improves parser performance, reducing the error
rate by at least 50%.
Dzikovska et al. [46] evaluated the eﬀectiveness of our
domain specialization technique that uses mapping rules
to convert the generic semantic representations to
domain-speciﬁc concepts. Our Medication Advisor domain
model contained 182 classes corresponding to domain-spe-
ciﬁc concepts. Mapping the generic parser ontology to the
new domain required 95 straightforward rules. We then
compared parsing speed and accuracy for specialized and
non-specialized versions of the grammar on a speech lattice
parsing task in which the parser must select the best
sequence of words from 50 possible interpretations output
by the speech recognizer. The use of the domain mapping
rules resulted in a 1.7 times speedup in the parser and
50% error rate reduction, dramatic improvements for a
small amount of eﬀort. To further improve parser perfor-
mance, we are enhancing our search and pruning algorithm
[47] and developing techniques for augmenting our deep
parsing with statistical methods [48,49].
Note that the goal of our system is accurate intention
recognition, not accurate whole-sentence linguistic analy-
ses. Our discourse processing techniques work well starting
from a set of meaningful fragments as long as the fragment
interpretations are semantically accurate. The critical capa-
bility for the system (as for people) is to robustly make
sense of what was heard and identify the intentions. Also
important is the ability to identify when an utterance is
not understood suﬃciently well and to produce a clariﬁca-
tion or conﬁrmation question to resolve the problem.
5.2. Evaluating intention recognition
The main barrier to using plan and intention recognition
within dialogue systems is that they are intractable in the
general case [37]. Systems which do utilize intention recog-
nition (e.g., [50]) tend to only use a small number of possi-
ble goals, as we did in the Chester demonstration system.
Recent work in probabilistic goal recognition (e.g., [51])
has made goal recognition more tractable, but at a sacriﬁce
of representational power (typically, representation ofparameter values, among other things). These techniques
would be inadequate for a full Medication Advisor system.
To recognize intentions more generally without sacriﬁc-
ing expressive power, we have developed techniques that
use a combination of statistical and symbolic techniques.
The general idea is to use a fast statistical recognizer to
quickly identify an n-best set of possible intentions, and
then use these to focus the reasoning in a slower symbolic
intention recognizer. We have created a statistical goal rec-
ognizer which runs in time linear to the number of possible
goals, making it fast and scalable. At the same time, it is
also able to predict goal parameter values, as well as make
partial predictions for the cases where it is not yet sure
enough to make a full prediction [39]. We have evaluated
this recognizer in two diverse domains. In an emergency
planning domain with 10 possible goal schemas, using sim-
ulation-derived data, we were able to get 96.4% precision
and 67.5% recall for 3-best prediction, with the recognizer
converging on the correct answer after only having
observed a little more than half of the actions. In an oper-
ating system domain (Linux) with 19 possible goal sche-
mas, and based on actual user sessions, the recognizer
achieved 68.8% precision and 38.7% recall for the 3-best
prediction. An in-depth discussion of the diﬀerent results
can be found in [39].
5.3. Evaluating pronunciation modeling
In Section 3.1, we mentioned how diﬃcult it is to ﬁnd
pronunciations for words in the Medication Advisor
domain and suggested that automatic techniques could
prove helpful. In order to assess the magnitude of the prob-
lem, we collected all the words in the seven MedlinePlus
HTML ﬁles used for knowledge acquisition. There were
1357 unique words, of which 529 (39%) were missing from
the CMU Dictionary.
As explained above, our proposed solution is to use a
grapheme-to-phoneme converter to obtain pronunciations
for out-of-dictionary words. Although our joint n-gram
model for bi-directional grapheme to phoneme conversion
has demonstrated excellent performance both on random
words [33] and on more diﬃcult, specialized cases like
names [52], we expect the lack of domain-speciﬁc training
to make the Medication Advisor domain diﬃcult to
handle.
The Merriam-Webster medical dictionary, accessible
from the MedlinePlus website, supplies a deﬁnition and
pronunciation for only 267 of the 529 words. This is further
proof that even specialized dictionaries fail to cover a large
proportion of the medical terms, especially proprietary
names (of the 262 words not included, about 200 are brand
names). The 267 words include 68 proprietary drug names
and 184 non-proprietary drug names and drug types; the
majority of the other 15 words are disease names.
We created our reference set by transcribing the pronun-
ciations using the CMU Dictionary phoneme set and con-
ventions, including multiple pronunciations where given.
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converter to generate pronunciations for all the test words,
and compared the hypothesized pronunciations to those in
the reference set. The results for both the top hypothesis (1-
best) and top 10 hypotheses (10-best) are shown in Fig. 5.
The bottom part of the ﬁgure shows word accuracies (full
pronunciation is correctly hypothesized) and the top dis-
plays phoneme error rates (summing over substitutions,
deletion, and insertion rates). We include results that disre-
gard confusions between schwa and other vowels, which
account for the majority of the errors—a typical type of
error in grapheme-to-phoneme conversion, but one that a
recognizer can recover from easily if given enough context.
Overall, the word accuracy is rather low, especially for
the best hypothesis (22–25%). Note that the same model’s
performance on general vocabulary exceeds 70% word
accuracy [33]. Ten-best performance (40–63% word accura-
cy) is markedly improved, which indicates that adding
domain-speciﬁc data to the training of the model would
prove very helpful.
When we compared the results for proprietary drug
names and non-proprietary drug names we were surprised
to ﬁnd that the former were somewhat easier to pronounce.
In part, this is probably due to the manufacturers’ desire to
ﬁnd easy to remember names—hence easy to pronounce—
for their drugs, though it is often the case that in their quest
for uniqueness, they break the grapho-phonotactic rules of
English. Again, a more detailed analysis of the errors for
non-proprietary drugs reveals that many errors are system-
atic and could be easily avoided with a small amount of
domain-speciﬁc data.
These results in no way should be taken as indications of
likely recognition results on these words, given that many
factors contribute to a speech recognizer’s performance.
However, they do provide hope that including automatical-
ly generated pronunciations in a dictionary to be used by a 0
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Fig. 5. Grapheme-to-phoneme conversion resultsspeech recognizer has signiﬁcant potential. Only a direct
evaluation of continuously spoken utterances from real
speakers will give us precise clues as to how much.
6. Conclusions and future work
The Chester system suggests a promising avenue of
research addressing the important societal problem of help-
ing people manage their medications. As we have
described, it also presents a variety of challenges to our cur-
rent understanding of how to build such systems. As we
hoped, the main eﬀort in building the initial Chester system
involved designing and implementing the back-end medica-
tion reasoning systems. The generic components actually
worked reasonably well on this new domain out of the
box without modiﬁcation. And the domain specialization
techniques proved to be eﬀective at improving the accuracy
and eﬃciency of the parser.
We believe that the Medication Advisor is just the tip of
the iceberg in terms of providing a conversational assistant
that can help people take care of their health in their
homes. Ultimately, we hope to expand the Medication
Advisor into a more general ‘‘Personal Medical Assistant,’’
which will integrate the information provided by the vari-
ous technologies and provide a personalized point of con-
tact for the residents of the home. The goal is not to
replace doctors, nurses, or pharmacists. Rather, we want
to provide systems that can help people better manage their
part of their health care, and connect them to health care
providers, family members, and the broader community
as appropriate. We are in the early going, of course, but
the need is great and growing, and the future looks very
interesting.
Before tackling these more ambitious goals, however, we
plan to demonstrate that robust, usable systems can be
eﬀective in simple, but real, applications. At present, we10-best
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on words in the Medication Advisor domain.
512 J. Allen et al. / Journal of Biomedical Informatics 39 (2006) 500–513are exploring possible options with collaborators in the
University of Rochester Medical School. We are looking
at problems where eﬀective techniques are known but they
are too expensive (in terms of personnel) to implement.
Besides the prescription compliance problem, we are also
investigating systems that help patients with congestive
heart failure and a system for advising on diet.
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